IP Library › Granted Patent US 12,318,588
Granted Patent B2
US 12,318,588 · App. 17/883,230 · Granted Jun 3, 2025

Assembly for a drug delivery device and drug delivery device

Inventors: Michael Strehl (Frankfurt am Main, DE); Udo Leuschner (Frankfurt am Main, DE); Norbert Besenhardt (Frankfurt am Main, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/31536A61M5/24A61M5/2422A61M5/31511A61M5/31541A61M5/3155A61M5/31551A61M5/31556A61M5/31561A61M2005/2407A61M2005/2411A61M2005/2488A61M2005/3104A61M2005/3154A61M5/3158A61M5/31586
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,318,588
App. No.
17/883,230
Granted
Jun 3, 2025
Kind
B2
Abstract

An assembly for a drug delivery device comprises a housing, a dose member which is displaceable in a proximal direction with respect to the housing for setting of a dose of a drug, a clutch member which is displaced in the proximal direction with respect to the housing when setting the dose, and a stop member configured to define a clutch stop position. The clutch member and the dose member are configured to mechanically cooperate with one another when the clutch member is in the clutch stop position, thereby preventing further displacement of the dose member in the proximal direction with respect to the housing during setting of the dose.

Claims (43)

1. An assembly for a drug delivery device, comprising:

a housing having a proximal end and a distal end;

a dose member configured to be displaced in a proximal direction with respect to the housing during setting of a dose of a drug;

a clutch member configured to be displaced in the proximal direction with respect to the housing during setting of the dose; and

a stop member configured to define a clutch stop position for the clutch member, the clutch member, when in the clutch stop position, being prevented from further displacement in the proximal direction with respect to the housing,

wherein the clutch member and the dose member are configured to mechanically cooperate with one another when the clutch member is in the clutch stop position, thereby preventing further displacement of the dose member in the proximal direction with respect to the housing during setting of the dose,

wherein the stop member is configured to be displaced in a distal direction with respect to the housing during delivery of the dose,

wherein the dose member is threadedly connected to the housing and wherein the dose member is configured to rotate in a first direction with respect to the housing and to be displaced in the proximal direction with respect to the housing during setting of the dose, and

wherein rotation of the dose member in the first direction with respect to the housing is prevented or stopped when the dose member and the clutch member cooperate mechanically.

2. The assembly of claim 1 , comprising a clutch spring member that prevents the dose member from cooperating mechanically with the clutch member when the clutch member is out of the clutch stop position.

3. The assembly of claim 2 , wherein the clutch spring member is configured to bias the dose member and the clutch member away from one another.

4. The assembly of claim 1 , wherein the dose member and the clutch member are configured to mechanically cooperate to prevent rotational movement of the dose member with respect to the clutch member in the first direction and to permit rotational movement of the dose member with respect to the clutch member in a second direction opposite to the first direction.

5. The assembly of claim 1 , wherein the clutch member is secured against rotation with respect to the housing.

6. The assembly of claim 1 , wherein the clutch member follows displacement of the dose member in the proximal direction with respect to the housing during setting of the dose.

7. The assembly of claim 1 , wherein the clutch member is connected to the dose member.

8. The assembly of claim 1 , comprising a piston rod configured to be displaced in the distal direction with respect to the housing during delivery of the dose, wherein the clutch stop position is displaced in the distal direction with respect to the housing together with the piston rod.

9. The assembly of claim 8 , wherein the stop member is integral with or connected to the piston rod.

10. The assembly of claim 9 , wherein the stop member is defined by a distal end of a drive thread of the piston rod.

11. The assembly of claim 1 , comprising a dose dial member configured to rotate and to be displaced in the proximal direction with respect to the housing during setting of the dose, wherein the dose member is splined to the dose dial member during setting of the dose.

12. A drug delivery device, comprising:

an assembly comprising

a housing having a proximal end and a distal end;

a dose member configured to be displaced in a proximal direction with respect to the housing during setting of a dose of a drug;

a clutch member configured to be displaced in the proximal direction with respect to the housing during setting of the dose; and

a stop member configured to define a clutch stop position for the clutch member, the clutch member, when in the clutch stop position, being prevented from further displacement in the proximal direction with respect to the housing,

wherein the clutch member and the dose member are configured to mechanically cooperate with one another when the clutch member is in the clutch stop position, thereby preventing further displacement of the dose member in the proximal direction with respect to the housing during setting of the dose,

wherein the stop member is configured to be displaced in a distal direction with respect to the housing during delivery of the dose; and

a cartridge containing the drug, the cartridge having a proximal end and a distal end, a piston retained within the cartridge, the piston being displaceable in the distal direction with respect to the cartridge for dispensing the dose of the drug from the cartridge,

wherein a position of the stop member with respect to the distal end of the cartridge is indicative of an amount of drug currently available in the cartridge and the assembly is an end stop assembly configured to prevent setting of a dose that exceeds the amount of drug currently available in the cartridge, wherein as one or more doses of the drug are dispensed from the cartridge, the stop member is successively displaced towards the distal end of the cartridge, thereby indicating that less drug is left in the cartridge.

13. The drug delivery device of claim 12 , comprising a clutch spring member that prevents the dose member from cooperating mechanically with the clutch member when the clutch member is out of the clutch stop position.

14. The drug delivery device of claim 13 , wherein the clutch spring member is configured to bias the dose member and the clutch member away from one another.

15. The drug delivery device of claim 12 , wherein the dose member is threadedly connected to the housing and wherein the dose member is configured to rotate in a first direction with respect to the housing and to be displaced in the proximal direction with respect to the housing during setting of the dose.

16. The drug delivery device of claim 15 , wherein rotation of the dose member in the first direction with respect to the housing is prevented or stopped when the dose member and the clutch member cooperate mechanically.

17. The drug delivery device of claim 12 , wherein the clutch member is secured against rotation with respect to the housing.

18. The drug delivery device of claim 12 , wherein the clutch member follows displacement of the dose member in the proximal direction with respect to the housing during setting of the dose.

19. An assembly for a drug delivery device, comprising:

a housing having a proximal end and a distal end;

a dose member configured to be displaced in a proximal direction with respect to the housing during setting of a dose of a drug;

a clutch member configured to be displaced in the proximal direction with respect to the housing during setting of the dose;

a stop member configured to define a clutch stop position for the clutch member, the clutch member, when in the clutch stop position, being prevented from further displacement in the proximal direction with respect to the housing,

wherein the clutch member and the dose member are configured to mechanically cooperate with one another when the clutch member is in the clutch stop position, thereby preventing further displacement of the dose member in the proximal direction with respect to the housing during setting of the dose,

wherein the stop member is configured to be displaced in a distal direction with respect to the housing during delivery of the dose; and

a clutch spring member that prevents the dose member from cooperating mechanically with the clutch member when the clutch member is out of the clutch stop position.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2022
From: STREHL, MICHAEL; LEUSCHNER, UDO; BESENHARDT, NORBERT
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 061706/0195 →
Priority Claims (1)
EP 09007297 · Jun 2, 2009 · regional
Continuity (6)
Continuation 17395061 · Aug 5, 2021
Continuation 16379773 · Apr 9, 2019
Continuation 15455172 · Mar 10, 2017
Continuation 13375441
Provisional Application 61239557 · Sep 3, 2009
Related Publication 20220379037A1 · Dec 1, 2022
References Cited (185)
US 533575A · Wilkens · 1895 [cited by applicant]
US 4865591A · Sams · 1989 [cited by applicant]
US 5092842A · Bechtold et al. · 1992 [cited by applicant]
US 5226895A · Harris · 1993 [cited by applicant]
US 5226896A · Harris · 1993 [cited by applicant]
US 5279586A · Balkwill · 1994 [cited by applicant]
US 5304152A · Sams · 1994 [cited by applicant]
US 5320609A · Haber et al. · 1994 [cited by applicant]
US 5378233A · Haber et al. · 1995 [cited by applicant]
US 5383865A · Michel · 1995 [cited by applicant]
US 5391157A · Harris et al. · 1995 [cited by applicant]
US 5480387A · Gabriel et al. · 1996 [cited by applicant]
US 5505704A · Pawelka et al. · 1996 [cited by applicant]
US 5582598A · Chanoch · 1996 [cited by applicant]
US 5626566A · Petersen et al. · 1997 [cited by applicant]
US 5674204A · Chanoch · 1997 [cited by applicant]
US 5688251A · Chanoch · 1997 [cited by applicant]
US 5807346A · Frezza · 1998 [cited by applicant]
US 5820602A · Kovelman et al. · 1998 [cited by applicant]
US 5851079A · Horstman et al. · 1998 [cited by applicant]
US 5921966A · Bendek et al. · 1999 [cited by applicant]
US 5957896A · Bendek et al. · 1999 [cited by applicant]
US 5961495A · Walters et al. · 1999 [cited by applicant]
US 6004297A · Steenfeldt-Jensen et al. · 1999 [cited by applicant]
US 6193698B1 · Kirchhofer et al. · 2001 [cited by applicant]
US 6221046B1 · Burroughs et al. · 2001 [cited by applicant]
US 6235004B1 · Steenfeldt-Jensen et al. · 2001 [cited by applicant]
US 6248095B1 · Giambattista et al. · 2001 [cited by applicant]
US 6562006B1 · Hjertman et al. · 2003 [cited by applicant]
US 6582404B1 · Klitgaard et al. · 2003 [cited by applicant]
US 6613023B2 · Kirchhofer et al. · 2003 [cited by applicant]
US 6699224B2 · Kirchhofer et al. · 2004 [cited by applicant]
US 6899698B2 · Sams · 2005 [cited by applicant]
US 6932794B2 · Giambattista et al. · 2005 [cited by applicant]
US 6936032B1 · Bush, Jr. et al. · 2005 [cited by applicant]
US 7169132B2 · Bendek et al. · 2007 [cited by applicant]
US 7195616B2 · Diller et al. · 2007 [cited by applicant]
US 7241278B2 · Møller · 2007 [cited by applicant]
US 7678084B2 · Judson et al. · 2010 [cited by applicant]
US 7850662B2 · Veasey et al. · 2010 [cited by applicant]
US 8186233B2 · Joung et al. · 2012 [cited by applicant]
US 8366680B2 · Raab · 2013 [cited by applicant]
US 8491538B2 · Kohlbrenner et al. · 2013 [cited by applicant]
US 8920383B2 · Enggaard et al. · 2014 [cited by applicant]
US 9089652B2 · Nzike et al. · 2015 [cited by applicant]
US 10286154B2 · Strehl · 2019 [cited by examiner]
US 11167093B2 · Strehl · 2021 [cited by examiner]
US 11324894B2 · Strehl et al. · 2022 [cited by applicant]
US 20020052578A1 · Moller · 2002 [cited by applicant]
US 20020120235A1 · Enggaard · 2002 [cited by applicant]
US 20030050609A1 · Sams · 2003 [cited by applicant]
US 20040059299A1 · Moller · 2004 [cited by applicant]
US 20040097883A1 · Roe · 2004 [cited by applicant]
US 20040127858A1 · Bendek et al. · 2004 [cited by applicant]
US 20040186442A1 · Graf et al. · 2004 [cited by applicant]
US 20040210199A1 · Atterbury et al. · 2004 [cited by applicant]
US 20040260247A1 · Veasey et al. · 2004 [cited by applicant]
US 20040267207A1 · Veasey et al. · 2004 [cited by applicant]
US 20050033244A1 · Veasey et al. · 2005 [cited by applicant]
US 20050113765A1 · Veasey et al. · 2005 [cited by applicant]
US 20060153693A1 · Fiechter et al. · 2006 [cited by applicant]
US 20070016142A1 · Burren et al. · 2007 [cited by applicant]
US 20070016143A1 · Miller et al. · 2007 [cited by applicant]
US 20080234634A1 · Eiland et al. · 2008 [cited by applicant]
US 20090054851A1 · Radmer et al. · 2009 [cited by applicant]
US 20090275916A1 · Harms · 2009 [cited by examiner]
US 20100152672A1 · Raab · 2010 [cited by applicant]
US 20140194830A1 · Nzike et al. · 2014 [cited by applicant]
CA 2138528 · 1998 [cited by applicant]
CA 2359375 · 2000 [cited by applicant]
CN 1723054 · 2006 [cited by applicant]
CN 101227942 · 2008 [cited by applicant]
CN 101227943 · 2008 [cited by applicant]
DE 20023819 · 2006 [cited by applicant]
DE 102005023823 · 2006 [cited by applicant]
EA 200600783 · 2006 [cited by applicant]
EP 0496141 · 1992 [cited by applicant]
EP 0673482 · 1998 [cited by applicant]
EP 0897729 · 1999 [cited by applicant]
EP 0937471 · 1999 [cited by applicant]
EP 0937476 · 1999 [cited by applicant]
EP 1304129 · 2003 [cited by applicant]
EP 1776975 · 2007 [cited by applicant]
GB 517500 · 1940 [cited by applicant]
GB 0304823 · 2003 [cited by applicant]
GB 3024822S · 2006 [cited by applicant]
JP 2006501026 · 2006 [cited by applicant]
JP 2006501036 · 2006 [cited by applicant]
JP 2008529690 · 2008 [cited by applicant]
JP 2009502273 · 2009 [cited by applicant]
JP 2009502274 · 2009 [cited by applicant]
JP 2010503433 · 2010 [cited by applicant]
JP 2012511358 · 2012 [cited by applicant]
KR 1020070048750 · 2007 [cited by applicant]
RU 2212253 · 2003 [cited by applicant]
RU 2283142 · 2006 [cited by applicant]
TW 200507897 · 2005 [cited by applicant]
WO WO1993007922 · 1993 [cited by applicant]
WO WO1993024160 · 1993 [cited by applicant]
WO WO1999038554 · 1999 [cited by applicant]
WO WO2001010484 · 2001 [cited by applicant]
WO WO2001072361 · 2001 [cited by applicant]
WO WO2002030495 · 2002 [cited by applicant]
WO WO2002092153 · 2002 [cited by applicant]
WO WO2003080160 · 2003 [cited by applicant]
WO WO2004030762 · 2004 [cited by applicant]
WO WO2004078239 · 2004 [cited by applicant]
WO WO2005039676 · 2005 [cited by applicant]
WO WO2005053778 · 2005 [cited by applicant]
WO WO2006024461 · 2006 [cited by applicant]
WO WO2006037434 · 2006 [cited by applicant]
WO WO2006040296 · 2006 [cited by applicant]
WO WO2006084876 · 2006 [cited by applicant]
WO WO2007017052 · 2007 [cited by applicant]
WO WO2007017053 · 2007 [cited by applicant]
WO WO2008031235 · 2008 [cited by applicant]
WO WO2008031238 · 2008 [cited by applicant]
WO WO2008148540 · 2008 [cited by applicant]
WO WO2009132778 · 2009 [cited by applicant]
WO WO2010139691 · 2010 [cited by applicant]
“Pen-injectors for medical use—Part 1: Pen-injectors—Requirements and test methods,” International Standard, reference No. ISO 11608-1:2000(E), first edition Dec. 15, 2000, 32 pages. [cited by applicant]
Acknowledgement of Receipt for European Patent Application No. 10723101.1, dated Dec. 6, 2011, 1 page. [cited by applicant]
Advice of Delivery in European Patent Application No. 10723101.1 sent to Keil & Schaafhausen, dated Sep. 26, 2015, 1 page. [cited by applicant]
Advice of Delivery in European Patent Application No. 10723101.1 sent to Samson & Partner, dated Oct. 16, 2015, 1 page. [cited by applicant]
Advice of Delivery sent to Keil & Schaafhausen, dated Sep. 26, 2015, 2 pages. [cited by applicant]
Advice of Delivery sent to Samson & Partner, dated Sep. 29, 2015, 2 pages. [cited by applicant]
Amended Claims with Annotations, dated Dec. 10, 2014, 4 pages. [cited by applicant]
Amended Claims with Annotations, dated Dec. 9, 2014, 4 pages. [cited by applicant]
Annex to the Communication-Opposition-issued in European Patent No. 10723101.1, dated Sep. 22, 2015, 2 pages. [cited by applicant]
Bibliographic data of the European Patent Application No. 10723101.1, dated Jan. 7, 2013, 2 pages. [cited by applicant]
Brief Communication of Opposition proceedings issued in European Patent Application No. 100723101.1 sent to Keil & Schaafhausen, dated Apr. 17, 2015, 1 page. [cited by applicant]
Brief Communication of Opposition proceedings issued in European Patent Application No. 100723101.1 sent to Keil & Schaafhausen, dated Aug. 12, 2015, 1 page. [cited by applicant]
Brief Communication Opposition Proceeding issued in European Patent Application No. 10723101.1 sent to Keil & Schaafhausen, dated Oct. 10, 2014, 1 page. [cited by applicant]
Brief Communication Opposition Proceedings issued in European Patent Application 10723101.1 sent to Samson & Partner, dated Jun. 24, 2014, 2 pages. [cited by applicant]
Brief communication regarding opposition proceedings issued in European Patent Application No. 10723101.1 sent to Keil & Schaafhausen, dated Aug. 24, 2015, 1 page. [cited by applicant]
Brief communication regarding opposition proceedings issued in European Patent Application No. 10723101.1 sent to Samson & Partner, dated Aug. 20, 2015, 1 page. [cited by applicant]
Brief Communication-Opposition Proceedings issued in European Patent Application No. 10723101.1 sent to Samson & Partner, dated Oct. 10, 2014, 1 page. [cited by applicant]
Brief communication-opposition proceedings sent to Samson & Partner, dated Aug. 12, 2015, 1 page. [cited by applicant]
Certified priority document of European Patent Application No. 09007297.6, dated Dec. 31, 2010. [cited by applicant]
Certified priority document of U.S. Appl. No. 61/239,557, dated Dec. 31, 2010. [cited by applicant]
Claims, dated Dec. 10, 2014, 4 pages. [cited by applicant]
Claims, dated Dec. 9, 2014, 4 pages. [cited by applicant]
Client Database System (CDS)—Clean up, amended applicant details, dated Feb. 3, 2014, 1 page. [cited by applicant]
Communication about Intention to grant a European patent sent to Sanofi-Aventis Deutschland GmbH, dated Jan. 7, 2013, 5 pages. [cited by applicant]
Communication of a Notice of Opposition and First Information to Patent Proprietor sent to Sanofi-Aventis Deutschland Gmbh, dated May 7, 2014, 1 page. [cited by applicant]
Communication of Amended Entries Concerning the Representative sent to Keil & Schaafhausen, dated Jun. 24, 2014, 1 page. [cited by applicant]
Communication of Amended Entries issued in European Patent Application No. 10723101.1 sent to Samson & Partner, dated Apr. 17, 2015, 2 pages. [cited by applicant]
Communication of Notice of Opposition and Request to file Observations sent to Sanofi-Aventis Deutschland Gmbh, dated Jun. 3, 2014, 1 page. [cited by applicant]
Communication regarding Comments on written opinion/amendment of Application/payment of claims fee sent to Sanofi-Aventis Deutschland GmbH, dated Jan. 17, 2012, 2 pages. [cited by applicant]
Communication regarding the forthcoming Grant sent to Sanofi-Aventis Deutschland GmbH, dated May 14, 2013, 1 page. [cited by applicant]
Decision to Grant a European patent sent to Sanofi-Aventis Deutschland GmbH, dated Jun. 27, 2013, 2 pages. [cited by applicant]
English Translation of Notification of Reasons for Refusal issued in Japanese Patent Application No. 2012-513599, dated Mar. 31, 2014, 7 pages. [cited by applicant]
Extended European Search Report, issued in European Patent Application No. 09007297.6, dated Dec. 11, 2009, 4 pages. [cited by applicant]
Filing of the Translations of the Claims sent by Sanofi-Aventis Deutschland GmbH, dated May 3, 2013, 1 page. [cited by applicant]
Form PCT/IB/326, Notification Concerning Transmittal of International Preliminary Report on Patentability, mailed Dec. 15, 2011, 1 page. [cited by applicant]
Form PCT/ISA/220, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, dated Aug. 18, 2010. [cited by applicant]
French translation of the claims, dated May 3, 2013, 3 pages. [cited by applicant]
General Authorization sent to Keil & Schaafhausen, dated Jul. 5, 2012, 1 page. [cited by applicant]
German translation of the claims, dated May 3, 2013, 4 pages. [cited by applicant]
Grant of Extension of Time limit issued in European Patent Application No. 10723101.1 sent to Keil & Schaafhausen, dated Oct. 10, 2014, 1 page. [cited by applicant]
Information concerning oral proceeding issued in European Patent Application No. 10723101.1 sent to Keil & Schaafhausen, dated Sep. 22, 2015, 3 pages. [cited by applicant]
Information concerning oral proceeding issued in European Patent Application No. 10723101.1 sent to Samson & Partner, dated Sep. 22, 2015, 3 pages. [cited by applicant]
Information on Entry into the European Phase sent to Sanofi-Aventis Deutschland GmbH, dated Oct. 14, 2011, 3 pages. [cited by applicant]
Intention to Grant (Signatures), dated Jan. 7, 2013, 1 page. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2010/057633, dated Dec. 6, 2011, 4 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2010/057633, mailed Aug. 18, 2010, 8 pages. [cited by applicant]
Keil & Schaafhausen Request for Interpreters during oral proceedings, dated Aug. 20, 2015, 1 page. [cited by applicant]
Letter regarding the Opposition Procedure (no time limit) sent by Samson & Partner, dated Apr. 24, 2014, 31 pages. [cited by applicant]
Notice of further opposition to opponent(s) sent to Samson & Partner, dated Jun. 3, 2014, 1 page. [cited by applicant]
Notice of Opposition, dated Apr. 24, 2014, 5 pages. [cited by applicant]
Notification of Forthcoming Publication of Bibliographic Data sent to Sanofi-Aventis Deutschland GmbH, dated Mar. 14, 2012, 1 page. [cited by applicant]
Patent Examination Report No. 1, issued in Australian Patent Application No. 2010255777, dated Apr. 11, 2014, 3 pages. [cited by applicant]
Payment of Fees and Expenses from Samson & Partner, dated Apr. 24, 2014, 1 page. [cited by applicant]
Preparation for Oral Proceedings issued in European Patent Application No. 10723101.1, dated Sep. 22, 2015, 2 pages. [cited by applicant]
Reply of the Patent Proprietor to the Notice(s) of Opposition sent by Keil & Schaafhausen, dated Dec. 10, 2014, 12 pages. [cited by applicant]
Reply of the Patent Proprietor to the Notice(s) of Opposition sent by Keil & Schaafhausen, dated Dec. 9, 2014, 12 pages. [cited by applicant]
Request for Change of Applicant's Representative sent by Keil & Schaafhausen, dated Jun. 18, 2014, 1 page. [cited by applicant]
Request for Change of Opponents Representative sent by Samson & Partner, dated Apr. 2, 2015, 1 page. [cited by applicant]
Request for Entry into the European Phase, dated Dec. 6, 2011, 4 pages. [cited by applicant]
Request for Extension of Time limit sent by Keil & Schaafhausen, dated Oct. 6, 2014, 1 page. [cited by applicant]
Samson & Partner Request for Interpreters during oral proceedings, dated Aug. 20, 2015, 1 page. [cited by applicant]
Summons to attend oral proceedings issued in European Patent Application No. 10723101.1 sent to Keil & Schaafhausen, dated Sep. 22, 2015, 1 page. [cited by applicant]
Summons to attend oral proceedings issued in European Patent Application No. 10723101.1 sent to Samson & Partner, dated Sep. 22, 2015, 1 page. [cited by applicant]
Text intended for Grant, dated Jan. 7, 2013. [cited by applicant]
Transmission of the Certificate for a European Patent sent to Sanofi-Aventis Deutschland GmbH, dated Jul. 26, 2013, 1 page. [cited by applicant]